MicroRNAs in Cancer Therapy: Recent Advances and Prospects
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: 20 January 2025 | Viewed by 416
Special Issue Editor
Interests: pharmacogenomics; pharmacoepigenetics; nanomedicine; toxicity of cancer chemotherapy; biological evaluation of natural compounds; cardiovascular diseases
Special Issue Information
Dear Colleagues,
The abnormal expression of microRNAs (miRNAs), which are regulatory small non-coding RNAs, occurs in pathological events such as cancer. Their extraordinary regulatory potential, which enables the regulation of entire signalling networks within the cells, makes them an interesting tool for the development of cancer therapeutics. The pattern of miRNAs expression can be correlated with the cancer type, stage, and other clinical variables. It has been demonstrated that miRNAs are implicated in almost all aspects of cancer biology, such as proliferation, apoptosis, invasion/metastasis, and angiogenesis. A number of miRNAs affect the growth of cancer cells in vitro and in vivo when overexpressed or inhibited. Therefore, cancer cell growth can be controlled by manipulating miRNAs.
In this Special Issue of Pharmaceutics, original articles and comprehensive reviews that present novel anticancer strategies with a focus on miRNAs exhibting experimentally proven therapeutic potential and that discuss recent advances in the technical development and clinical evaluation of miRNA-based therapeutic agents are welcome. These strategies should address the optimization of cancer therapies that could offer remarkable clinical value in the near future. We therefore encourage the submission of articles that focus on the development and validation of various novel anticancer approaches including, but not limited to, synthetic miRNA mimics such as the siRNA-like oligoribonucleotide duplex or chemically modified oligoribonucleotide, and strategies involving miRNA delivery using liposomes, viral vectors and nanoparticles, among others.
Prof. Dr. Luis A. Salazar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer therapy
- miRNA mimics
- miRNA delivery
- oligoribonucleotide
- siRNA-like oligoribonucleotide
- drug delivery
- therapy resistance
- miRNA antagonists
- viral vectors
- LNA-modified oligonucleotides
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
